loading

Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten

pulisher
Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Dec 21, 2024
pulisher
Dec 19, 2024

Wellington Management Group LLP Sells 26,207 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

The Take On Tyra Biosciences (NASDAQ:TYRA) - Seeking Alpha

Dec 17, 2024
pulisher
Dec 17, 2024

(TYRA) Trading Signals - Stock Traders Daily

Dec 17, 2024
pulisher
Dec 16, 2024

Tyra Biosciences to Present at Upcoming Investor Conferences - The Eastern Progress Online

Dec 16, 2024
pulisher
Dec 14, 2024

Charles Schwab Investment Management Inc. Increases Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Dec 14, 2024
pulisher
Dec 10, 2024

Frazier Life Sciences Management L.P. Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET - Victoria Advocate

Dec 09, 2024
pulisher
Dec 08, 2024

Janus Henderson Group PLC Takes Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 07, 2024

Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 06, 2024

(TYRA) Investment Analysis - Stock Traders Daily

Dec 06, 2024
pulisher
Dec 06, 2024

Polar Asset Management Partners Inc. Buys New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Tyra Biosciences to Participate in 2023 Jefferies London Healthc - GuruFocus.com

Dec 05, 2024
pulisher
Dec 03, 2024

Walleye Capital LLC Has $2.98 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Dec 03, 2024
pulisher
Nov 29, 2024

Sio Capital Management LLC Has $9.42 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Nov 29, 2024
pulisher
Nov 15, 2024

How to Take Advantage of moves in (TYRA) - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5%Here's Why - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Short Interest in Tyra Biosciences, Inc. (NASDAQ:TYRA) Drops By 20.0% - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Gap UpWhat's Next? - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

RA Capital Management, L.P. Increases Stake in Tyra Biosciences Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Equities Analysts Offer Predictions for TYRA FY2024 Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Tyra Biosciences to Present FGFR Precision Medicine Updates at Major Healthcare Conferences - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Increases Stake in Tyra Biosciences Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Tyra Biosciences stock target cut, retains buy rating on clinical data - Investing.com Canada

Nov 12, 2024
pulisher
Nov 11, 2024

HC Wainwright Has Lowered Expectations for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Tyra Biosciences director Nina Kjellson sells $1.28 million in stock By Investing.com - Investing.com Australia

Nov 10, 2024
pulisher
Nov 08, 2024

Tyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Tyra Biosciences director Nina Kjellson sells $1.28 million in stock - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Tyra Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights - PR Newswire

Nov 07, 2024
pulisher
Nov 06, 2024

Tyra Biosciences director Nina S. Kjellson sells shares worth $194k - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Auour Investments LLC - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Long Term Trading Analysis for (TYRA) - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 04, 2024

Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Insider Buying Activity - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

Tyra Biosciences director Nina Kjellson sells $2.28m in stock By Investing.com - Investing.com Australia

Nov 02, 2024
pulisher
Nov 02, 2024

Tyra Biosciences director Nina Kjellson sells $2.28m in stock - Investing.com

Nov 02, 2024
pulisher
Nov 02, 2024

Tyra Biosciences, Inc. (NASDAQ:TYRA) CFO Purchases $152,000.00 in Stock - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Tyra Biosciences CFO Alan Fuhrman acquires $151,954 in stock By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Tyra Biosciences CFO Alan Fuhrman acquires $151,954 in stock - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma - Urology Times

Oct 31, 2024
pulisher
Oct 29, 2024

Tyra Biosciences (NASDAQ:TYRA) Trading Down 10.2%Here's What Happened - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Tyra Biosciences advances with Phase 2 trial for achondroplasia treatment By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Tyra Biosciences advances with Phase 2 trial for achondroplasia treatment - Investing.com

Oct 29, 2024
pulisher
Oct 29, 2024

Piper Sandler maintains Overweight on Tyra Biosciences stock By Investing.com - Investing.com Canada

Oct 29, 2024
pulisher
Oct 28, 2024

Tyra Biosciences stock target lifted, retains buy on clinical trial data - Investing.com Canada

Oct 28, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):